Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record for the trial of recombinant human prourokinase in acute pulmonary embolism is displayed, with details on its design, participants, and measured outcomes. It also lists a related 2026 publication.
    Difference
    61%
    Check dated 2026-11-08T03:14:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T23:15:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T23:14:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T23:33:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page shows the site revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T23:33:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied message. This indicates the study record at this URL is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-19T22:24:48.000Z thumbnail image

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.